Mass spectrometry tool to advance cancer and biology research
Official title: Acquisition of a Matrix-Assisted Laser Desorption/Ionization Mass Spectrometer
Funded at Clarkson University · NIH-11336454 · Data updated 2026-11-12
A MALDI mass spectrometer will be acquired to support breast cancer research and broader biological studies by Clarkson University researchers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Clarkson University NIH-funded |
| Lab location | 1 site (Potsdam, United States) |
| Project start | September 1, 2026 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $350,000 |
| NIH project number | 1S10OD040197-01 |
| Project ID | NIH-11336454 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with breast cancer or related conditions who contribute samples (serum, milk) or participate in studies using the instrument’s outputs may benefit from faster, more precise biomarker discovery.
✕Less likely to help
Patients whose samples are not part of the instrument-enabled studies or who are not candidates for the specific projects may not directly benefit.
What this research studies
This grant funds the purchase of a MALDI-MS instrument to enable detailed molecular analysis of proteins, peptides, and other biomolecules in human samples and model systems. Researchers plan to use the instrument on breast cancer-related samples (including patient serum and milk) and on cell and animal models to study cellular processes and disease mechanisms. The tool will also support development of new imaging reporters and studies in zebrafish and Drosophila, with broader applications in biology. Access to the instrument will be shared among multiple projects to accelerate discovery. The grant focuses on enabling high-throughput, sensitive analysis to generate data that could inform future diagnostics and therapies.
Why it matters
Potential benefit: This instrument could accelerate discoveries that improve understanding and treatment of breast cancer and other diseases.
How similar studies have gone: Previous MALDI-MS applications have successfully advanced proteomics and biomarker research in cancer and other diseases.
Where this research is happening
-
Clarkson University
Potsdam, United States Active
Researchers
- Principal investigator: Darie, Costel C. — Clarkson University
- Study coordinator: Darie, Costel C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.